New combo attack on deadly cancer
NCT ID NCT04926948
Summary
This early-stage study is testing whether combining a very precise form of radiation therapy with immunotherapy is safe and feasible for people with mesothelioma, a type of cancer. The goal is to see if this two-part approach can better control the cancer while causing fewer side effects. The study will enroll about 20 patients to monitor their health and track how the cancer responds over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLEURAL MESOTHELIAL NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.